The TNFRSF10B receptor and its ligand, TRAIL, have been reported to preferentially induce apoptosis in transformed and tumor cells even though it is expressed at a significant level and may be induced in normal tissues [38, 39]. Here, TNFSF10 is linked to neoplasm.